At a glance
- Originator Aventis; University of Bonn
- Class Antipsychotics; Indoles; Small molecules
- Mechanism of Action Dopamine D1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Psychotic disorders
Most Recent Events
- 26 Jun 2001 No-Development-Reported for Psychotic disorders in Germany (Unknown route)
- 19 Jun 1997 Preclinical development for Psychotic disorders in Germany (Unknown route)